Ugandan firm Dei BioPharma lodges seven US mRNA cancer-vaccine patents by Nakaweesi Destiny August 31, 2026 0 62 KAMPALA — Ugandan biotechnology firm Dei BioPharma has filed seven ground-breaking patents in the United States patent covering a modular portfolio of messenger RNA (mRNA) cancer-vaccine technologies, the company announced, ...